S'abonner

Parental Assessment of Pain Control Following Pediatric Circumcision: Do Opioids Make a Difference? - 11/08/21

Doi : 10.1016/j.urology.2020.12.027 
Adam C. Adler a, , Arvind Chandrakantan b, Thanh V. Dang c, Andrew D. Lee d, Paul F. Austin e
a Department of Anesthesiology, Perioperative and Pain Medicine; Texas Children's Hospital; Baylor College of Medicine, Houston, TX 
b Department of Anesthesiology, Perioperative and Pain Medicine; Texas Children's Hospital; Baylor College of Medicine, Houston, TX 
c Baylor College of Medicine, Houston, TX 
d Department of Anesthesiology, Perioperative and Pain Medicine; Texas Children's Hospital 
e Division of Pediatric Urology, Department of Surgery, Texas Children's Hospital; Baylor College of Medicine, Houston, TX 

Address correspondence to: Adam C. Adler, M.S., M.D., F.A.A.P., F.A.S.E., Department of Anesthesiology, Perioperative and Pain Medicine; Texas Children's Hospital; Baylor College of Medicine, 6621 Fannin Street, Suite #A3300, Houston TX 77030.Department of AnesthesiologyPerioperative and Pain Medicine; Texas Children's Hospital; Baylor College of Medicine6621 Fannin Street, Suite #A3300HoustonTX77030

Abstract

Objective

To determine whether a postoperative prescription for opioids affects parental assessment of pain control following pediatric circumcision.

Methods

This postoperative survey assessed the parental assessment of pain control in 199 patients, ages<18 years undergoing circumcision. This study was conducted at a quaternary care children's hospital in Houston, Texas from December 2018 to January 2020. Postoperative pain regimens included acetaminophen and ibuprofen or combination hydrocodone/acetaminophen in addition to ibuprofen for postoperative analgesia based on the surgical preference. The primary study outcome was identification of the proportion of parents rating their child's analgesia following pediatric circumcision as poor or inadequate based on the postoperative analgesic regimen.

Results

Of the 502 surveys sent, the response rate was 40% (199/502) of those who received the survey email, and 64% (199/308) for those who opened the email. Between the opioid and nonopioid groups, there was no difference in, race/ethnicity (Caucasian; 28% vs 37%; P = .43) or insurance status (insured; 51% vs 45%; P = .44). The proportion of parents who rated their child's pain as poor or inadequately controlled following circumcision was relatively rare:5.5% and 1.1% in the nonopioid and opioid groups, respectively. Parents rating their child's pain as excellent with regards to pain control following circumcision were 61% and 53% in the nonopioids and opioid groups, respectively.

Conclusion

The results of this study indicate that nonopioid analgesic regimens following pediatric circumcision were not associated with decreased parental satisfaction or an increasing assessment of poor or inadequately controlled pain. Limiting opioid exposure following pediatric circumcision is feasible and does not result in worse parental satisfaction with the analgesic plan.

Le texte complet de cet article est disponible en PDF.

Plan


 Financial Disclosures: Dr. Austin is a consultant to Allergan and Urovant. The remainder of the authors have no potential, perceived or real conflicts of interest.
 Funding Support: This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
 A portion of the manuscript was presented in abstract form at the American Academy of Pediatrics Meeting, October 2019, New Orleans LA.


© 2021  Elsevier Inc. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 154

P. 263-267 - août 2021 Retour au numéro
Article précédent Article précédent
  • Renal Transplants Due to Congenital Anomalies of the Kidney and Urinary Tract (CAKUT) Have Better Graft Survival Than Non-CAKUT Controls: Analysis of Over 10,000 Patients
  • Laura B. Cornwell, Elizabeth G. Ingulli, Matthew D. Mason, Emily Ewing, Jonathan V. Riddell
| Article suivant Article suivant
  • Inflammatory Myofibroblastic Tumor Presenting as Gross Hematuria in a Pediatric Patient With VACTERL Syndrome Following Bladder Augmentation
  • Akshay Chandora, Jennifer M. Lovin, Edwin A. Smith

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.